High resolution NMR based analysis of serum lipids in Duchenne muscular dystrophy patients and its possible diagnostic significance

NMR in Biomedicine

Volumn 23, Issue 1, 2010, Pages 13-22

  Srivastava, Niraj Kumar ^a   Pradhan, Sunil ^a   Mittal, Balraj ^a   Gowda, G A Nagana ^a,b  

^a SANJAY GANDHI POSTGRADUATE INSTITUTE OF MEDICAL SCIENCES   (India)

^b PURDUE UNIVERSITY   (United States)

Author keywords

1H NMR spectroscopy; Cholesterol; DMD; Lipid extraction; Muscular dystrophy; Phospholipids; Serum lipid profile; Triglycerides

Indexed keywords

1H-NMR SPECTROSCOPY; LIPID EXTRACTION; MUSCULAR DYSTROPHY; NMR SPECTROSCOPY; SERUM LIPID;

BODY FLUIDS; ESTERIFICATION; ESTERS; NUCLEAR MAGNETIC RESONANCE; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PHOSPHOLIPIDS;

CHOLESTEROL;

CHOLESTEROL; CHOLESTEROL ESTER; LIPID; PHOSPHOLIPID; TRIACYLGLYCEROL;

ARTICLE; CHILD; CHOLESTEROL BLOOD LEVEL; CLINICAL ARTICLE; CONTROLLED STUDY; DIAGNOSTIC VALUE; DUCHENNE MUSCULAR DYSTROPHY; FEMALE; GENE DELETION; GENETIC ANALYSIS; HUMAN; INDIA; LIPID ANALYSIS; LIPID BLOOD LEVEL; MALE; PHOSPHOLIPID BLOOD LEVEL; PRIORITY JOURNAL; PROTON NUCLEAR MAGNETIC RESONANCE; SCHOOL CHILD; TRIACYLGLYCEROL BLOOD LEVEL;

ADOLESCENT; CHILD; CHILD, PRESCHOOL; DYSTROPHIN; ELECTROMYOGRAPHY; HUMANS; LIPID METABOLISM; LIPIDS; MAGNETIC RESONANCE SPECTROSCOPY; MUSCLE, SKELETAL; MUSCULAR DYSTROPHY, DUCHENNE;

EID: 75149121046     PISSN: 09523480     EISSN: 10991492     Source Type: Journal    
DOI: 10.1002/nbm.1419     Document Type: Article

References (45)

1. Monckton G, Hoskin V, Warren S. Prevalence and incidence of muscular dystrophy in Alberta, Canada. Clin. Genet. 1982; 21: 19-24.
2. Koenig M, Hoffman EP, Bertelson CJ, Monaco AP, Feener C, Kunkel LM. Complete cloning of the Duchenne muscular dystrophy (DMD) cDNA and preliminary genomic organization of the DMD gene in normal and affected individuals. Cell 1987; 50: 509-517.
3. Yiu EM, Kornberg AJ. Duchenne muscular dystrophy. Neurol. India 2008; 56: 236-247.
4. Ervasti JM, Ohlendieck K, Kahl SD, Gaver MG, Campbell KP. Deficiency of a glycoprotein component of the dystrophin complex in dystrophic muscle. Nature 1990; 345: 315-319.
5. Rando TA. The dystrophin-glycoprotein complex, cellular signaling, and the regulation of cell survival in the muscular dystrophies. Muscle Nerve 2001; 24: 1575-1594.
6. Emery AEH. Muscular Dystrophy, 2nd edn. Oxford Medical Publications: Oxford, 1993.
7. Gardner RJ, Bobrow M, Roberts RG. The identification of point mutations in Duchenne muscular dystrophy using reverse transcript PCR and the protein truncation test. Am. J. Hum. Genet. 1995; 57: 311-320.
8. Beggs AH, Koening M, Boyce FM, Kunkel LM. Detection of 98% of DMD/BMD gene deletion by polymerase chain reaction. Hum. Genet. 1990; 86: 45-48.
9. Chamberlain JS, Gibbs RA, Ranier JE, Nguyen PN, Caskey C. Deletion screening of the Duchenne muscular dystrophy locus via multiplex DNA amplification. Nucleic Acids Res. 1988; 16: 11141-11156.
10. Emery AEH. The muscular dystrophies. Lancet 2002; 359: 687-695.
11. Nishio H, Wada H, Matsuo T, Horikawa H, Takahashi K, Nakajima T, Matsuo M, Nakamura H. Glucose, free fatty acid and ketone body metabolism in Duchenne muscular dystrophy. Brain Dev. 1990; 12: 390-402.
12. Plishker GA, Appel SH. Red blood cell alterations in muscular dystrophy: the role of lipids. Muscle Nerve 1980; 3: 70-81.
13. Oostendorp M, Engelke UF, Willemsen MA, Wevers RA. Diagnosing inborn errors of lipid metabolism with proton nuclear magnetic resonance spectroscopy. Clin. Chem. 2006; 52: 1395-1405.
14. Pradhan S. New clinical sign in Duchenne muscular dystrophy. Pediatr. Neurol. 1994; 11: 298-300.
15. Pradhan S. Valley sign in Duchenne muscular dystrophy: importance in patients with inconspicuous calves. Neurol. India 2002; 2: 184-186.
16. Olerup O, Zetterquist H. HLA-DR typing by PCR amplification with sequence-specific primers (PCR-SSP) in 2 hours: an alternative to serological DR typing in clinical practice including donor-recipient matching in cadaveric transplantation. Tissue Antigens 1992; 39: 225-235.
17. Chamberlain JS, Gibbs RA, Ranier JE, Caskey CT. Multiplex PCR for the diagnosis of Duchenne muscular dystrophy. In PCR protocols. A Guide to Methods and Application. Academic Press: New York, 1990; 272-281.
18. Sinha S, Pradhan S, Mittal RD, Mittal B. Detection of gene deletion in patients of Duchenne/Becker muscular dystrophy (D/BMD) patients using Polymerase chain reaction. Indian J. Med. Res. 1992; 96: 297-301.
19. Mittal B, Singh V, Misra S, Sinha S, Mittal RD, Chaturvedi LS, Danda S, Pradhan S, Agarwal SS. Genotype-phenotype correlation in Duchenne/ Becker muscular dystrophy patients seen at Lucknow. Indian J. Med. Res. 1997; 105: 32-38.
20. Chaturvedi LS, Mukherjee M, Srivastava S, Mittal RD, Mittal B. Point mutation and polymorphism in Duchenne/Becker muscular dystrophy (D/BMD) patients. Exp. Mol. Med. 2001; 33: 251-256.
21. Singh V, Sinha S, Mishra S, Chaturvedi LS, Pradhan S, Mittal RD, Mittal B. Proportion and pattern of dystrophin gene deletions in North Indian Duchenne and Becker muscular dystrophy patients. Hum. Genet. 1997; 99: 206-208.
22. Hughes BP. A method for the estimation of serum creatine kinase and its use in comparing creatine kinase and aldolase activity in normal and pathological sera. Clin. Chim. Acta 1962; 7: 597-603.
23. Ennor AH, Stocken LA. The application of the diacetyl reaction to the estimation of creatine in urine. Biochem. J. 1953; 55: 310-314.
24. Srivastava N, Pradhan S, Mittal B, Kumar R, Gowda G. An improved, single step standarderized method of lipid extraction from human skeletal muscle tissue. Anal. Lett. 2006; 39: 297-315.
25. Tofts PS, Wray S. A critical assessment of methods of measuring metabolite concentrations by NMR spectroscopy. NMR Biomed. 1988; 1: 1-10.
26. Cady E. Determination of absolute concentrations of metabolites from NMR spectra. NMR Basic Princ. Prog. 1992; 26: 249-281.
27. Subramanian A, Shankar Joshi B, Roy AD, Roy R, Gupta V, Dang RS. NMR spectroscopic identification of cholesterol esters, plasmalogen and phenolic glycolipids as fingerprint markers of human intracranial tuberculomas. NMR Biomed. 2008; 21: 272-288.
28. Charak A. Charak Samhita (Original Sanskrit text with English translation), Vol. II, III and IV. Shree Gulabkunverba Ayurvedic Society: Jamnagar (India), 1949.
29. Gouri-Devi M, Venkatram BS. Concept of disorders of muscles in 'Charak Samhita', an ancient Indian medical treatise - relevance to modern myology. Neurol. India 1983; 31: 13-14.
30. Chio LF, Peterson DW, Kratzer FH. Lipid composition and synthesis in the muscles of normal and dystrophic chickens. Can. J. Biochem. 1972; 50: 1267-1272.
31. Kwok CT, Kuffer AD, Tang BY, Austin L. Phospholipid metabolism in murine muscular dystrophy. Exp. Neurol. 1976; 50: 362-375.
32. Kwok CT, Austin L. Phospholipids composition and metabolism in mouse muscular dystrophy. Biochem. J. 1978; 176: 15-22.
33. Shull RL, Alfin-Slater RB. Tissue lipids of dystrophia muscularis, a mouse with inherited muscular dystrophy. Proc. Soc. Exp. Biol. Med. 1958; 92: 403-405.
34. Jato-Rodriguez JJ, Hudson AJ, Strickland KP. Triglycerides metabolism in skeletal muscle from normal and dystrophic mice. Biochim. Biophys. Acta 1974; 348: 1-13.
35. Smith TA, Yau SC, Bobrow M, Abbs SJ. Identification and quantification of somatic mosaicism for a point mutation in a Duchenne muscular dystrophy family. J. Med. Gen. 1999; 36: 313-315.
36. David LN, Michael MC. Lehninger Principle of Biochemistry, 3rd edn. Worth publishers: New York, 2002; 368-381.
37. Iyer SL, Katyare SS, Howland JL. Elevated erythrocyte phospholipase A associated with Duchenne and myotonic muscular dystrophy. Neurosci. Lett. 1976; 2: 103-106.
38. Marggraf WD, Anderer FA. Alternative pathways in the biosynthesis of sphingomyelin and the role of phosphatidylcholine, CDP-choline and phosphorylcholine as precursors. Hoppe-Seyler's Z. Physiol. Chem. 1974; 355: 803-810.
39. Ullman ML, Radin NS. The enzymatic formation of sphingomyelin from ceramide in mouse liver. J. Biol. Chem. 1974; 249: 1506-1512.
40. Kanfer JN, Spielvogel CH. Phospholipase C catalyzed formation of sphingomyelin - 14C from lecithin and N-(-14C)-oleoyl-sphingosine. Lipids 1975; 10: 391-394.
41. Batetta B, Pani A, Putzolu M, Sanna F, Bonatesta R, Piras S, Spano O, Mulas MF, Dessi, S. Correlation between cholesterol esterification, MDR1 gene expression and rate of cell proliferation in CEM and MOLT4 cell lines. Cell Prolif. 1999; 32: 49-61.
42. Brown MS, Ho YK, Goldstein JL. The cholesteryl ester cycle in macrophage from cells. J. Biol. Chem. 1980; 255: 9344-9352.
43. Kotcharian A, Mohammadi A, Mojtahedzadeh R. Hyperlipidemia in 12 year-old children living in Tehran. Acta Med. Iran. 2000; 40: 20-25.
44. Horri M, Vakili R. Evaluation of cardiovascular and lipid profile abnormalities in obese children and adolescents. Iran. J. Med. Sci. 2006; 31: 87-90.
45. Krishna P, Roopakala KM, Kumar P. Dyslipidemia in type 1 diabetes mellitus in the young. Int. J. Diab. Dev. Ctries 2005; 25: 110-112.